Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Автор: | Rahman, Tasnim |
---|---|
Інші автори: | Azam, Faruque |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
Brac University
2024
|
Предмети: | |
Онлайн доступ: | http://hdl.handle.net/10361/22174 |
Схожі ресурси
-
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
за авторством: Paul, Pulock
Опубліковано: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Flora, Sanzida Alam
Опубліковано: (2024) -
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
за авторством: Hoque, Ismoth Ara
Опубліковано: (2024) -
Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Karim, Samia Binte
Опубліковано: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
за авторством: Mim, Shanzida
Опубліковано: (2023)